Advertisement

Annals of Hematology

, Volume 95, Issue 12, pp 2065–2076 | Cite as

How can we help haematological cancer survivors cope with the changes they experience as a result of their cancer?

  • Alix HallEmail author
  • Marita Lynagh
  • Flora Tzelepis
  • Chris Paul
  • Jamie Bryant
Original Article
  • 288 Downloads

Abstract

Haematological cancer often necessitates that individuals make significant lifestyle and behaviour changes to protect themselves against infections. It is essential that haematological cancer survivors receive the support and information they require to adjust to such changes. This cross-sectional survey of 259 haematological cancer survivors found that over two thirds of haematological cancer survivors would like to receive more detailed information or help with: diet and nutrition that takes into account their diagnosis and treatment, how to manage the symptoms from the cancer and/or treatment, signs and symptoms to be aware of that may indicate a possible infection and appropriate exercise. Over a third of survivors reported that they had to make changes to reduce their chance of infection, with social restriction the most commonly reported area of change survivors made. Improving communication and access to care and providing additional emotional support may assist survivors in making these additional changes. Healthcare providers should use this information to better support haematological cancer survivors in dealing with the effects haematological cancer has on their life.

Keywords

Lifestyle changes Information Support Survivors 

Notes

Acknowledgments

This grant No. 569290 was awarded through the Priority-driven Collaborative Cancer Research Scheme and co-funded by beyondblue and the Australian Government through Cancer Australia. It also received funding support from a Strategic Research Partnership Grant (CSR 11-02) from Cancer Council NSW to the Newcastle Cancer Control Collaborative (New-3C), and infrastructure funding from the University of Newcastle and Hunter Medical Research Institute. Flora Tzelepis was supported by a Leukaemia Foundation of Australia and Cure Cancer Australia Foundation Post-Doctoral Research Fellowship. Christine Paul is supported by an NHMRC Career Development Fellowship (APP1061335). Jamie Bryant is supported by an Australian Research Council Post-Doctoral Industry Fellowship. The authors are grateful for all the hard work and assistance of the registry staff, for multiple research personnel, including Ms. Sandra Dowley for data entry; Miss Hannah Small, Miss Lara Ryan, Mr Scott Stronach and Ms Natalie Dodd for assistance with data cleaning; and Ms Alessandra Bisquera for statistical support. The authors would also like to acknowledge the time and effort provided by the survivors who took part in this research; the authors greatly appreciate their involvement, as without their assistance this research would not be possible.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Mehnert A (2011) Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol 77(2):109–130CrossRefPubMedGoogle Scholar
  2. 2.
    Duijts SFA, van Egmond MP, Spelten E, van Muijen P, Anema JR, van der Beek AJ (2014) Physical and psychosocial problems in cancer survivors beyond return to work: a systematic review. Psychooncology 23:481–492CrossRefPubMedGoogle Scholar
  3. 3.
    Brearley SG, Stamataki Z, Addington-Hall J, Foster C, Hodges L, Jarrett N, Richardson A, Scott I, Sharpe M, Stark D, Siller C, Ziegler L, Amir Z (2011) The physical and practical problems experienced by cancer survivors: a rapid review and synthesis of the literature. Eur J Cancer Care 15:204–212Google Scholar
  4. 4.
    Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M (2010) It’s not over when it’s over: long-term symptoms in cancer survivors—a systematic review. Int’l J Psychiatry in Medicine 40(2):163–181CrossRefGoogle Scholar
  5. 5.
    Hess LM, Huang HQ, Hanlon AL, Robinson WR, Johnson R, Chambers SK, Mannel RS, Puls L, Davidson SA, Method M, Lele S, Havrilesky L, Nelson T, Alberts DS (2015) Cognitive function and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: an NRG oncology/gynecologic oncology group study. Gynecol Oncol 139:541–545CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Mosher CE, Redd WH, Rini CM, Burkhalter JE, DuHamel KN (2009) Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psychooncology 18:113–127CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    O’Farrell E, MacKenzie J, Collins B (2013) Clearing the air: a review of our current understanding of “Chemo Fog”. Curr Oncol Rep 15:260–269CrossRefPubMedGoogle Scholar
  8. 8.
    Blinder VS, Griggs JJ (2013) Health disparities and the cancer survivor. Semin Oncol 40(6):796–803CrossRefPubMedGoogle Scholar
  9. 9.
    Islam T, Dahlui M, Majid HA, Nahar AM, Taib NAM, Su TT, MyBCC study group (2014) Factors associated with return to work of breast cancer survivors: a systematic review. BMC Public Health 14(Suppl 3):S8CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Blinder V, Patil S, Eberle C, Griggs J, Maly RC (2013) Early predictors of not returning to work in low-income breast cancer survivors: a 5-year longitudinal study. Breast Cancer Res Treat 140:407–416CrossRefPubMedGoogle Scholar
  11. 11.
    Kleinberg M (2010) Managing infections in patients with hematological malignancies. Humana Press, New YorkCrossRefGoogle Scholar
  12. 12.
    National Comprehensive Cancer Network (2015) NCCN Clinical Practice Guidelines In Oncology (NCCN Guidelines). Prevention and treatment of cancer-related infectionsGoogle Scholar
  13. 13.
    Girmenia C, Menichetti F (2011) Current epidemiology and prevention of infectious complications in cancer patients. Eur Oncol Haematol 7:270–277CrossRefGoogle Scholar
  14. 14.
    Nørgaard M (2012) Risk of infections in adult patients with haematological malignancies. The Open Infectious Diseases Journal 6(1):46–51Google Scholar
  15. 15.
    Ludwig H, Zojer N (2008) Recent therapeutic advances in hematological malignancies: dealing with treatment-related complications. Ann Oncol 19(suppl 5):v71–v78CrossRefPubMedGoogle Scholar
  16. 16.
    Morrison VA (2009) Infectious complications in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approaches to prophylaxis. Clin Lymphoma Myeloma 9(5):365–370CrossRefPubMedGoogle Scholar
  17. 17.
    Khayr W, Haddad RY, Noor SA (2012) Infections in hematological malignancies. Dis Mon 58(4):239–249CrossRefPubMedGoogle Scholar
  18. 18.
    Bacigalupo A, Sormani MP, Lamparelli T, Gualandi F, Occhini D, Bregante S, Raiola AM, di Grazia C, Dominietto A, Tedone E (2004) Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation. Haematologica 89(10):1238–1247PubMedGoogle Scholar
  19. 19.
    Martín‐Peña A, Aguilar‐Guisado M, Espigado I, Parody R, Miguel Cisneros J (2011) Prospective study of infectious complications in allogeneic hematopoietic stem cell transplant recipients. Clin Transplant 25(3):468–474CrossRefPubMedGoogle Scholar
  20. 20.
    Hahn-Ast C, Glasmacher A, Mückter S, Schmitz A, Kraemer A, Marklein G, Brossart P, von Lilienfeld-Toal M (2010) Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006. J Antimicrob Chemother 65(4):761–768CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Baden LR, Bensinger W, Angarone M, Casper C, Dubberke ER, Freifeld AG, Garzon R, Greene JN, Greer JP, Ito JI (2012) Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw 10(11):1412–1445PubMedGoogle Scholar
  22. 22.
    Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, Wingard JR, Young J-AH, Boeckh MA (2009) Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 15(10):1143–1238CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Ruhnke M, Arnold R, Gastmeier P (2014) Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteria. Lancet Oncol 15(13):e606–e619CrossRefPubMedGoogle Scholar
  24. 24.
    Akan H, Antia VP, Kouba M, Sinkó J, Tănase AD, Vrhovac R, Herbrecht R (2013) Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects. J Antimicrob Chemother 68(suppl 3):iii5–iii16CrossRefPubMedGoogle Scholar
  25. 25.
    Kruger W, Bohlius J, Cornely O, Einsele H, Hebart H, Massenkeil G, Schuttrumpf S, Silling G, Ullmann A, Waldschmidt D, Wolf H (2005) Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Oncology. Ann Oncol 16(8):1381–1390. doi: 10.1093/annonc/mdi238 CrossRefPubMedGoogle Scholar
  26. 26.
    Ariza-Heredia EJ, Chemaly RF (2014) Infection control practices in patients with hematological malignancies and multidrug-resistant organisms: special considerations and challenges. Clin Lymphoma Myeloma Leukemia 14:S104–S110CrossRefGoogle Scholar
  27. 27.
    McInnes K, Lean C, Adams P, Sinclair S (2010) Review of Non-Inpatient Models of Care for Adult Patients with Haematological Malignancies. Final Report. Cancer Institute NSW, EveleighGoogle Scholar
  28. 28.
    Ringdén O, Le Blanc K (2005) Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives. Apmis 113(11-12):813–830Google Scholar
  29. 29.
    Dimatteo MR, Giordani PJ, Lepper HS, Croghan TW (2002) Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 40(9):794–811CrossRefPubMedGoogle Scholar
  30. 30.
    Hall AE, Paul C, Bryant J, Lynagh MC, Rowlings P, Enjeti A, Small H (2016) To adhere or not to adhere: rates and reasons of medication adherence in hematological cancer patients. Crit Rev Oncol Hematol 97:247–262CrossRefPubMedGoogle Scholar
  31. 31.
    Lynagh MC, Clinton-McHarg T, Hall A, Sanson-Fisher R, Stevenson W, Tiley C, Bisquera A (2015) Are Australian clinicians monitoring medication adherence in hematological cancer survivors? Two cross-sectional studies. Exp Hematol Oncol 4(1):1CrossRefGoogle Scholar
  32. 32.
    Hall A, D’Este C, Tzelepis F, Sanson-Fisher R, Lynagh M (2014) The Survivor Unmet Needs Survey (SUNS) for haematological cancer survivors: a cross-sectional study assessing the relevance and psychometric properties. BMC Health Serv Res 14:211CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Elo S, Kyngas H (2008) The qualitative content analysis process. JAN 62(1):107–115CrossRefGoogle Scholar
  34. 34.
    Driscoll DL, Appiah-Yeboah A, Salib P, Rupert D (2007) Merging qualitative and quantitative data in mixed methods research: how to and why not. Ecol Environ Anthropol 3(1):19–28Google Scholar
  35. 35.
    Maxwell JA (2010) Using numbers in qualitative research. Qual Inq 16(6):475–482CrossRefGoogle Scholar
  36. 36.
    Haq R, Heus L, Baker N, Dastur D, Leung FH, Leung E, Li B, Vu K, Parsons JA (2013) Designing a multifaceted survivorship care plan to meet the information and communication of breast cancer patients and their family physicians: results of a qualitative pilot study. BMC Med Inform Decis Mak 13:76CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Zebrack B (2009) Information and service needs for young adult cancer survivors. Support Care Cancer 17:349–357CrossRefPubMedGoogle Scholar
  38. 38.
    Zitella LJ, Friese CR, Hauser JJ, Gobel BH (2006) Putting evidence into practice: prevention of infection. Clin J Oncol Nurs 10(6):739CrossRefPubMedGoogle Scholar
  39. 39.
    Cunningham R (2013) Nutritional issues in patients with hematologic malignancies. In: Hematology. Basic Principles and Practice. 6th edn. Elsevier Inc, Philadelphia, p 1405-1417Google Scholar
  40. 40.
    Dunbar A, Tai E, Nielsen DB, Shropshire S, Richardson LC (2014) Preventing infections during cancer treatment: development of an interactive patient education website. Clin J Oncol Nurs 18(4):426CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Hall AE, Sanson-Fisher RW, Lynagh MC, Tzelepis F, D’Este C (2015) What do haematological cancer survivors want help with? A cross-sectional investigation of unmet supportive care needs. BMC Res Notes 8(1):221CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Leonard K (2012) A European survey relating to cancer therapy and neutropenic infections: nurse and patient viewpoints. Eur J Oncol Nurs 16(4):380–386CrossRefPubMedGoogle Scholar
  43. 43.
    Howell D, Mayo S, Currie S, Jones G, Boyle M, Hack T, Green E, Hoffman L, Collacutt V, McLeod D (2012) Psychosocial health care needs assessment of adult cancer patients: a consensus-based guideline. Support Care Cancer 20(12):3343–3354CrossRefPubMedGoogle Scholar
  44. 44.
    National Institute for Clinical Excellence (2003) Guidance on cancer services—improving outcomes in haematological cancers—the manual. National Health Service, LondonGoogle Scholar
  45. 45.
    Green HJ, Ferguson M, Shum DH, Chambers SK (2013) Prospective individual and social predictors of changes in adjustment for patients attending a regional cancer service. Qual Life Res 22(4):759–770CrossRefPubMedGoogle Scholar
  46. 46.
    Applebaum AJ, Stein EM, Lord‐Bessen J, Pessin H, Rosenfeld B, Breitbart W (2014) Optimism, social support, and mental health outcomes in patients with advanced cancer. Psychooncology 23(3):299–306CrossRefPubMedGoogle Scholar
  47. 47.
    Molassiotis A, Wilson B, Blair S, Howe T, Cavet J (2011) Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners. Psychooncology 20(1):88–97CrossRefPubMedGoogle Scholar
  48. 48.
    Lobb EA, Joske D, Butow P, Kristjanson L, Cannell P, Cull G, Augustson B (2009) When the safety net of treatment has been removed: patients’ unmet needs at the completion of treatment for haematological malignancies. Patient Educ Couns 77(1):103–108CrossRefPubMedGoogle Scholar
  49. 49.
    Hall A, Campbell HS, Sanson‐Fisher R, Lynagh M, D’Este C, Burkhalter R, Carey M (2013) Unmet needs of Australian and Canadian haematological cancer survivors: a cross-sectional international comparative study. Psychooncology 22(9):2032–2038CrossRefPubMedGoogle Scholar
  50. 50.
    Hall A, D’Este C, Tzelepis F, Lynagh M, Sanson-Fisher R (2014) Factors associated with haematological cancer survivors experiencing a high level of unmet need across multiple items of supportive care: a cross-sectional survey study. Support Care Cancer 22(11):2899–2909CrossRefPubMedGoogle Scholar
  51. 51.
    Hall AE, Sanson-Fisher RW, Lynagh MC, Threlfall T, D’Este CA (2013) Format and readability of an enhanced invitation letter did not affect participation rates in a cancer registry-based study: a randomized controlled trial. J Clin Epidemiol 66:85–94CrossRefPubMedGoogle Scholar
  52. 52.
    Clinton-McHarg T, Carey M, Sanson-Fisher RW, Tracey E (2011) Recruitment of representative samples for low incidence cancer populations: do registries deliver? BMC Med Res Methodol 11:5. doi: 10.1186/1471-2288-11-5 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Alix Hall
    • 1
    • 2
    Email author
  • Marita Lynagh
    • 1
    • 2
  • Flora Tzelepis
    • 1
    • 2
  • Chris Paul
    • 1
    • 2
  • Jamie Bryant
    • 1
    • 2
  1. 1.Priority Research Centre for Health Behaviour, Faculty of Health and MedicineThe University of NewcastleCallaghanAustralia
  2. 2.Hunter Medical Research InstituteNew Lambton HeightsAustralia

Personalised recommendations